AEG.L

Active Energy Group Plc
Active Energy Group - Financing update, board changes and joint broker
1st November 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4943K
Active Energy Group PLC
01 November 2024
 

 

1 November 2024

                                            

Active Energy Group plc

("Active Energy" or the "Company")

 

Financing update, board changes

and

appointment of joint broker

Active Energy (AIM: AEG, OTCQB: ATGVF), the biomass-based renewable energy company focused on the production and development of next generation biomass products, today announces a financing update, board changes and the appointment of a joint broker.

Financing update

On 15 October 2024 the Company announced that it had received an injection of £125,000 (the "Zen Loan") from Zen Ventures Limited ("Zen"). The proceeds of the Zen Loan are being used, inter alia, to fund the completion of the Company's audit for the year ended 31 December 2023 ("FY 2023") and completion of the unaudited interim results for the six months ended 30 June 2024 ("HY 2024").  Work continues to progress on the audit of the FY 2023 results and the preparation of the HY 2024 interim results, and the Board remain confident both will be completed and announced in December 2024.

The Company's ordinary shares, which were suspended from trading on AIM on 1 July 2024, will remain suspended from trading on AIM pursuant to AIM Rule 19, until the Company has published and posted its FY 2023 annual report and accounts and pursuant to AIM Rule 18 until the Company has published its HY 2024 interim results, at which point the Board hope that trading in the Company's ordinary shares on AIM will be restored.  In the event that the FY 2023 annual report and accounts and the H1 2024 interim results have not been published within six months of the date of suspension, then trading in the Company's ordinary shares on AIM will be cancelled.

On 31 October 2024 the Company and Zen agreed that Zen will advance a further £75,000 to the Company.  Following this advance the  funds advanced by Zen to the Company total £200,000. Zen and the Company have agreed that this amount will be used by Zen to subscribe for £200,000 of new loan notes issued by the Company (the "Loan Notes").  £27,616.02 of the Loan Notes will be convertible into 29.9 per cent of the Company's issued share capital, as enlarged by such conversion, at a price of £0.0004 per new ordinary share (the "Convertible").  The balance of the Loan Notes (being £172,383.98) will not be convertible into new shares in the Company at this time.  

The Loan Notes, which are subject to the terms of the loan note instrument dated 31 October 2024,  have a duration to 31 December 2024, are secured on the assets of the Company and do not carry a coupon (but will incur default interest of 8%).  The Convertible shall, subject to appropriate shareholder approvals, mandatorily convert into new ordinary shares in the Company 31 December 2024.

The Company intends, in due course, to send shareholders a circular seeking approval, inter alia, to obtain shareholder approval to issue new ordinary shares pursuant to the conversion of the Convertible.

Board changes

Max Aitken and Jason Zimmerman (both non-executive directors of the Company) have agreed to step down from the Board of Active Energy with immediate effect. Pursuant to the terms of the loan note instrument Zen has the ability to appoint two representatives to the Board following completion of satisfactory due diligence by the Company's nominated adviser. Further announcements on board appointments will be made as appropriate.

Appointment of Zeus Capital Limited as joint broker to the Company

The Company announces the appointment of Zeus Capital Limited as the Company's joint broker with immediate effect.

Enquiries: 

 

Active Energy Group Plc

Michael Rowan (Chief Executive Officer)

James Leahy (Non-Executive Chairman)

  info@aegplc.com

Allenby Capital Limited

Nominated Adviser and Joint Broker

Nick Naylor/James Reeve/Daniel Dearden-Williams (Corporate Finance)

Amrit Nahal (Sales/Corporate Broking)

Tel: +44 (0) 203 328 5656

Zeus

Joint Broker

Antonio Bossi, Alexandra Campbell-Harris (Investment Banking)

Tel: +44 (0) 203 829 5000

 

Website

LinkedIn

 Twitter

www.aegplc.com

www.linkedin.com/in/active-energy-group-plc/ 

 https://twitter.com/aegplc

@aegplc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZMFGNMFGDZM]]>
TwitterFacebookLinkedIn